|
Dr. Fabrizio Bonanni is Amgen's executive vice president, Operations, overseeing the company's global commercial production activities as well as site expansion and facilities management. Since joining Amgen in April 1999, Bonanni has served as senior vice president, Manufacturing; senior vice president, Quality and Compliance; and corporate compliance officer. Previously, he was corporate vice president, Regulatory and Clinical Affairs and corporate vice president, Quality System for Baxter International Inc., a company he joined in 1974. At Baxter, Bonanni spent half of his career in international operations, including an eight-year assignment as vice president, Quality and Regulatory Affairs, at the company's European headquarters in Brussels, Belgium. His responsibilities at Baxter included quality and regulatory affairs, manufacturing, microbiology and sterilization engineering, and total quality management, for (bio)pharmaceuticals, blood derivatives, medical devices and in-vitro diagnostics. Bonanni earned his doctorate in chemistry, magna cum laude, from the University of Florence and has done postdoctoral work in physiological chemistry at the Massachusetts Institute of Technology. He is a state-certified chemist and a member of the Ordine dei Chimici of Tuscany. He is an alumnus of the Institute for International Management, Northwestern University, J.L. Kellogg Graduate School of Management, and of the Executive Program in Manufacturing, Harvard University, Graduate School of Business Administration. Bonanni is fluent in French and English, in addition to his native Florentine Italian. Bonanni serves on the Board of Trustees for the Museum of Contemporary Art in Los Angeles. He also serves as a Trustee of the Science Technology and Research Trust of Puerto Rico. | 